• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Science . An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike

tetano

Editor, Senior Moderator
Science


. 2020 Nov 5;eabe3255.
doi: 10.1126/science.abe3255. Online ahead of print.
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike


Michael Schoof[SUP] #[/SUP][SUP] 1 2 [/SUP], Bryan Faust[SUP] #[/SUP][SUP] 3 2 4 5 [/SUP], Reuben A Saunders[SUP] #[/SUP][SUP] 3 6 [/SUP], Smriti Sangwan[SUP] #[/SUP][SUP] 3 2 [/SUP], Veronica Rezelj[SUP] #[/SUP][SUP] 7 [/SUP], Nick Hoppe[SUP] 4 5 [/SUP], Morgane Boone[SUP] 3 2 [/SUP], Christian B Billesb?lle[SUP] 4 5 [/SUP], Cristina Puchades[SUP] 5 [/SUP], Caleigh M Azumaya[SUP] 5 [/SUP], Huong T Kratochvil[SUP] 5 [/SUP], Marcell Zimanyi[SUP] 3 2 [/SUP], Ishan Deshpande[SUP] 4 5 [/SUP], Jiahao Liang[SUP] 4 [/SUP], Sasha Dickinson[SUP] 5 [/SUP], Henry C Nguyen[SUP] 5 [/SUP], Cynthia M Chio[SUP] 5 [/SUP], Gregory E Merz[SUP] 5 [/SUP], Michael C Thompson[SUP] 5 [/SUP], Devan Diwanji[SUP] 5 [/SUP], Kaitlin Schaefer[SUP] 5 [/SUP], Aditya A Anand[SUP] 3 2 [/SUP], Niv Dobzinski[SUP] 3 2 [/SUP], Beth Shoshana Zha[SUP] 8 [/SUP], Camille R Simoneau[SUP] 9 10 11 [/SUP], Kristoffer Leon[SUP] 9 10 11 [/SUP], Kris M White[SUP] 12 13 [/SUP], Un Seng Chio[SUP] 5 [/SUP], Meghna Gupta[SUP] 5 [/SUP], Mingliang Jin[SUP] 5 [/SUP], Fei Li[SUP] 5 [/SUP], Yanxin Liu[SUP] 5 [/SUP], Kaihua Zhang[SUP] 5 [/SUP], David Bulkley[SUP] 5 [/SUP], Ming Sun[SUP] 5 [/SUP], Amber M Smith[SUP] 5 [/SUP], Alexandrea N Rizo[SUP] 5 [/SUP], Frank Moss[SUP] 5 [/SUP], Axel F Brilot[SUP] 5 [/SUP], Sergei Pourmal[SUP] 5 [/SUP], Raphael Trenker[SUP] 5 [/SUP], Thomas Pospiech[SUP] 5 [/SUP], Sayan Gupta[SUP] 14 [/SUP], Benjamin Barsi-Rhyne[SUP] 4 [/SUP], Vladislav Belyy[SUP] 3 2 [/SUP], Andrew W Barile-Hill[SUP] 15 [/SUP], Silke Nock[SUP] 3 2 [/SUP], Yuwei Liu[SUP] 3 2 [/SUP], Nevan J Krogan[SUP] 5 6 9 10 [/SUP], Corie Y Ralston[SUP] 14 [/SUP], Danielle L Swaney[SUP] 5 6 9 10 [/SUP], Adolfo Garc?a-Sastre[SUP] 12 13 16 17 [/SUP], Melanie Ott[SUP] 9 10 11 [/SUP], Marco Vignuzzi[SUP] 7 [/SUP], QCRG Structural Biology Consortium; Peter Walter[SUP] 1 2 [/SUP], Aashish Manglik[SUP] 18 5 9 19 [/SUP]



Collaborators, Affiliations

Abstract

The SARS-CoV-2 virus enters host cells via an interaction between its Spike protein and the host cell receptor angiotensin converting enzyme 2 (ACE2). By screening a yeast surface-displayed library of synthetic nanobody sequences, we developed nanobodies that disrupt the interaction between Spike and ACE2. Cryogenic electron microscopy (cryo-EM) revealed that one nanobody, Nb6, binds Spike in a fully inactive conformation with its receptor binding domains (RBDs) locked into their inaccessible down-state, incapable of binding ACE2. Affinity maturation and structure-guided design of multivalency yielded a trivalent nanobody, mNb6-tri, with femtomolar affinity for Spike and picomolar neutralization of SARS-CoV-2 infection. mNb6-tri retains function after aerosolization, lyophilization, and heat treatment, which enables aerosol-mediated delivery of this potent neutralizer directly to the airway epithelia.
 
Back
Top Bottom